Navigation
Journal Content
|
Journal Content
|
Tamin Pharmaceutical Investment Compamy
|
|
|
|
| معرفی شرکت: |
Company:
Tamin Pharmaceutical Investment Company (TPICO) was established in 2003. This was a turning point in Iran's pharmaceutical industry, because it centralized the affairs of the country's leading pharmaceutical companies and enabled them to assume a strategic role in the industry.
The market share of TPICO and its affiliated companies in various pharmaceutical fields is as follows: more than 80% of raw materials, 35% of human drugs and 50% of animal drugs in Iran. This holding plays an essential role in the planning, organizing, staffing, coordinating, budgeting, and controlling of its affiliated companies in order to facilitate them in achieving their goals as well as ours. The policies of this holding are based on comprehensive studies, research and feasibility studies go hand in hand with the aims and plans of the pharmaceutical industry as a whole. The combined abilities and capacities of this holdings affiliated companies have created a situation in which we are able to maximize our capabilities in the fields of production, services, technology, finance, economic resources, human resources, R&D, consulting and timely decision making. Furthermore, this has enabled us to seize investment opportunities that are available at home and abroad.
Managers and staff of this sizable holding are adamant in achieving these goals and to coordinate and realize other rational long term plans. |
| |
|
| رسالت: |
Mission and Vision Statement:
Our mission in the largest pharmaceutical investment organization in Iran is to provide the most effective products so as to increase the health and well being of all mankind by utilizing the latest technology and effective management. In order to achieve this, we plan on employing the latest and most effective pharmaceuticals, active pharmaceutical ingredients, supplements and others. |
| |
|
| اهم فعالیتها: |
Company:
Tamin Pharmaceutical Investment Company (TPICO) was established in 2003. This was a turning point in Iran's pharmaceutical industry, because it centralized the affairs of the country's leading pharmaceutical companies and enabled them to assume a strategic role in the industry.
The market share of TPICO and its affiliated companies in various pharmaceutical fields is as follows: more than 80% of raw materials, 35% of human drugs and 50% of animal drugs in Iran. This holding plays an essential role in the planning, organizing, staffing, coordinating, budgeting, and controlling of its affiliated companies in order to facilitate them in achieving their goals as well as ours. The policies of this holding are based on comprehensive studies, research and feasibility studies go hand in hand with the aims and plans of the pharmaceutical industry as a whole. The combined abilities and capacities of this holdings affiliated companies have created a situation in which we are able to maximize our capabilities in the fields of production, services, technology, finance, economic resources, human resources, R&D, consulting and timely decision making. Furthermore, this has enabled us to seize investment opportunities that are available at home and abroad.
Managers and staff of this sizable holding are adamant in achieving these goals and to coordinate and realize other rational long term plans. |
| |
|
|
| آدرس دفتر مرکزی: |
#22,12th Street, Ahmadghasir Avenue, Argantine Square, Tehran |
|
|
|
| مديرعامل: |
Dr Morteza Azarnoosh |
|
|
|
|
|
|
|
اعضای هيئت مديره
|
مرتضی آذرنوش
|
مدیرعامل و نایب رئیس هیئت مدیره
|
|
فرخ ملک وند فرد
|
عضو هیئت مدیره
|
|
فرهاد زرگری
|
عضو هیئت مدیره
|
|
سیدمحمدسعید خلیلی
|
عضو هیئت مدیره
|
|
سید رمضان محسن پور
|
عضو هیئت مدیره
|
|
